Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c00995e210fd42587a5700b897689921 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
filingDate |
2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b9944b52ade01b0664897cbdd42da6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_340aeef62d197e238799102b52789c4a |
publicationDate |
2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008088080-A |
titleOfInvention |
G protein-coupled receptor inhibitor, medicine and screening method. |
abstract |
A substance that suppresses activation of a G protein-coupled receptor and a screening method thereof are provided. A G protein-coupled receptor inhibitor contains a compound selected from trans fatty acids as an active ingredient. Moreover, the pharmaceutical which contains a G protein coupled receptor inhibitor as an active ingredient can also be provided. Perform screening to detect substances that adversely affect the body or correct adverse effects by adding test compounds such as trans fatty acids to cells that possess activated G protein-coupled receptors. Can do. [Selection] Figure 5 |
priorityDate |
2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |